KromaTiD announces close of Series A fund round

KromaTiD announces close of Series A fund round

FORT COLLINS -- KromaTiD announced the successful closure of a Series A financing round. KromaTiD, provider of Directional Genomic Hybridization and Pinpoint FISH products, said it... Read More

Wednesday June 21, 2017 0 comments Tags: Fort Collins, KromaTid, Terry Opgenorth, Pinpoint FISH, Directional Genomic Hybridization, Christopher Tompkins, CSU Ventures

Rockies Venture Club to host investment program at Galvanize FoCo Oct. 5

Rockies Venture Club to host investment program at Galvanize FoCo Oct. 5

FORT COLLINS -- Rockies Venture Club and the City of Fort Collins will host a special event celebrating Northern Colorado startups on Oct. 5. Accelerate Northern Colorado Angel Investors... Read More

Friday September 30, 2016 0 comments Tags: Fort Collins, Rockies Venture Club, City of Fort Collins, Galvanize FoCo, Sam Houghteling, Charisse Bowen, Jes Rawley, Terry Opgenorth, Jesse Elliot, Alan Curits, Denny Otsuga, Stow, Vartega Carbon Fiber, KromaTid, BillGO

Summit: Precision medicine holds key to less costly, more effective cancer diagnosis and treatment

Summit: Precision medicine holds key to less costly, more effective cancer diagnosis and treatment

By Steve Porter LOVELAND Theres a new approach to treating cancer and other diseases that aims to be less costly and more effective than traditional methods. Its called precision... Read More

By: Steve Porter Monday August 1, 2016 0 comments Tags: Loveland, NoCoBio Cluster, Innosphere, Deanna Scott, Chris Tompkins, Biodesix, Paul Beresford, KromaTid, Steven Schuster, UCHealth North, Alan Rudolph, Unsu Jung, MCR, Dana Stangel, Dr. Gary Luckasen

KromaTiD receives third patent, expands mutation testing capabilities

KromaTiD receives third patent, expands mutation testing capabilities

FORT COLLINS -- KromaTiD announced it received its third U.S. patent to expand its full genome screening platform to include a new set of unique methods for understanding the structure of novel... Read More

Tuesday September 22, 2015 0 comments Tags: Fort Collins, KromaTid, Chris Tompkins, dGH

KromaTiD to distribute proprietary products and services in Japan

KromaTiD to distribute proprietary products and services in Japan

FORT COLLINS -- KromaTiD , a bioscience company dedicated to creating new products for genetic disease research, mutation detection and chromosome analysis, today announced an agreement with... Read More

By: InnovatioNews Monday May 18, 2015 0 comments Tags: Fort Collins, KromaTid, Tokyo Future Style, Alex Vodenlich, dGH, Pinpoint FISH

KromaTiD selects tebu-bio to distribute its products throughout Europe

KromaTiD selects tebu-bio to distribute its products throughout Europe

FORT COLLINS - KromaTiD announced it will partner with France-based tebu-bio to distribute its proprietary dGH and Pinpoint FISH products and services throughout Europe. Tebu-bio has... Read More

By: InnovatioNews Tuesday February 10, 2015 0 comments Tags: Alex Vodenlich, dGH, FISH, Fort Collins, KromaTid, Mark Livingstone, tebu-bio

KromaTiD launches directional Genomic Hybridization screening services for DNA tests

KromaTiD launches directional Genomic Hybridization screening services for DNA tests

FORT COLLINS - KromaTiD , a Colorado-based bioscience company dedicated to creating new products for genetic disease research, mutation detection and chromosome analysis, said it is... Read More

By: InnovatioNews Tuesday October 21, 2014 0 comments Tags: Alex Vodenlich, Fort Collins, KromaTid, Richard Duke

Three finalists selected for 2014 CBSA BioWest Venture Showcase pitch competition Sept. 10

Three finalists selected for 2014 CBSA BioWest Venture Showcase pitch competition Sept. 10

DENVER - Three finalists have been selected to pitch for $7,500 in cash during the BioWest Venture Showcase, part of the 2014 BioWest Conference set for Sept. 10 at the Marriott City... Read More

By: InnovatioNews Thursday August 21, 2014 0 comments Tags: dbMEDx, Denver, KromaTid, Margaret Hamburg, Mighty Oak Medical, Russell Slifer